Takao Yamori

发表

Inhibitory Activity of Flavonoids against Class I Phosphatidylinositol 3-Kinase Isoforms

Dexin Kong, Meihua Jin, T. Yamori, 2011, Molecules.

Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.

Takashi Tsuruo, Hiroshi Sakamoto, T. Tsuruo, 2003, Cancer research.

Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors

Takashi Tsuruo, Jiro Fujimoto, T. Tsuruo, 1999, Oncogene.

Improving Drug Potency and Efficacy by Nanocarrier-Mediated Subcellular Targeting

Yu Matsumoto, Kazunori Kataoka, Shourong Wu, 2011, Science Translational Medicine.

Antibacterial and antiproliferative activity of cationic fullerene derivatives.

Masataka Mochizuki, Takao Yamori, Tadahiko Mashino, 2003, Bioorganic & medicinal chemistry letters.

Identification of JTP‐70902, a p15INK4b‐inductive compound, as a novel MEK1/2 inhibitor

Makoto Koyama, Takayuki Yamaguchi, Kazuhide Hayakawa, 2007, Cancer science.

Modification of pyrimidine derivatives from antiviral agents to antitumor agents.

Yoshimasa Uehara, Takahiro Katoh, Takao Yamori, 2006, Anticancer research.

Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays

Noriyuki Nakatsu, Tomoki Nakamura, S. Dan, 2005, Molecular Cancer Therapeutics.

Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform.

Y. Kato, T. Yamori, Y. Nishimura, 2003, Biochemical and biophysical research communications.

Isolation of a Novel Gene Showing Reduced Expression in Metastatic Colorectal Carcinoma Cell Lines and Carcinomas

Yusuke Nakamura, Kouichi Ozaki, Takashi Tsuruo, 1997, Japanese journal of cancer research : Gann.

Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics

T. Yamori, Takao Yamori, 2003, Cancer Chemotherapy and Pharmacology.

Triterpene glycosides from Curculigo orchioides and their cytotoxic activity.

Koji Sato, T. Yamori, Takao Yamori, 2010, Journal of natural products.

AMF-26, a Novel Inhibitor of the Golgi System, Targeting ADP-ribosylation Factor 1 (Arf1) with Potential for Cancer Therapy

Shuichi Hirono, Noriyuki Yamaotsu, Hiroshi Iijima, 2011, The Journal of Biological Chemistry.

Effect on tumor cells of blocking survival response to glucose deprivation.

Takashi Tsuruo, Hae-Ryong Park, Kazuo Shin-ya, 2004, Journal of the National Cancer Institute.

Isolation and structures of biselyngbyasides B, C, and D from the marine cyanobacterium Lyngbya sp., and the biological activities of biselyngbyasides

Toshiyasu Inuzuka, T. Yamori, K. Suenaga, 2012 .

Cytotoxic activity of tivantinib (ARQ 197) is not due solely to c-MET inhibition.

Ryohei Katayama, Naoya Fujita, Jie Qi, 2013, Cancer research.

Triterpene saponins from the roots of Clematis chinensis.

T. Yamori, Takao Yamori, Akihito Yokosuka, 2004, Journal of natural products.

p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.

Takashi Tsuruo, Hiroshi Tomoda, Jun-ichi Hamada, 2005, Journal of the National Cancer Institute.